|
Index of reports
> Cases with Pyrexia (111)
Below is the selection of side effect reports (a.k.a. adverse event reports) related to Vincristine where reactions include pyrexia. The selected reports were submitted to the FDA during the sample period of about a year. Reports 1 - 30 of 111 Next >>
Possible Vincristine side effects in 49 year old male
Reported by a physician from Norway on 2012-08-27
Patient: 49 year old male
Reactions: Pneumocystis Jiroveci Pneumonia, Bone Marrow Failure, Pyrexia, Lung Infiltration, Septic Shock, Infection
Adverse event resulted in: death
Drug(s) suspected as cause:
Vincristine
Dosage: on day 8
Indication: Hodgkin's Disease
Bleomycin Sulfate
Dosage: on day 8
Indication: Hodgkin's Disease
Etoposide
Dosage: for the escalated cycles on day 1 to 3
Etoposide
Dosage: for the escalated cycles on day 1 to 3
Doxorubicin Hydrochloride
Dosage: for escalated cycles on day 1
Indication: Hodgkin's Disease
Prednisolone
Dosage: on day 1 to 14 every 21 day cycle treatment for 6 cycles
Administration route: Oral
Indication: Hodgkin's Disease
Doxorubicin Hydrochloride
Dosage: on day 1,for standard cycles
Cyclophosphamide
Dosage: for escalated cycles on day 1
Indication: Hodgkin's Disease
Etoposide
Dosage: for the standard cycles, day 1 to 3
Indication: Hodgkin's Disease
Cyclophosphamide
Dosage: for standard cycles on day 1
Procarbazine Hydrochloride
Dosage: day 1 to 7
Administration route: Oral
Indication: Hodgkin's Disease
Possible Vincristine side effects in 49 year old male
Reported by a physician from Norway on 2012-08-24
Patient: 49 year old male
Reactions: Pneumocystis Jiroveci Pneumonia, Bone Marrow Failure, Pyrexia, Lung Infiltration, Septic Shock, Infection
Adverse event resulted in: death
Drug(s) suspected as cause:
Bleomycin Sulfate
Dosage: on day 8
Indication: Hodgkin's Disease
Etoposide
Dosage: for the escalated cycles on day 1 to 3
Cyclophosphamide
Dosage: for escalated cycles on day 1
Indication: Hodgkin's Disease
Etoposide
Dosage: for the escalated cycles on day 1 to 3
Cyclophosphamide
Dosage: for standard cycles on day 1
Doxorubicin Hydrochloride
Dosage: on day 1,for standard cycles
Vincristine
Dosage: on day 8
Indication: Hodgkin's Disease
Procarbazine Hydrochloride
Dosage: day 1 to 7
Administration route: Oral
Indication: Hodgkin's Disease
Doxorubicin Hydrochloride
Dosage: for escalated cycles on day 1
Indication: Hodgkin's Disease
Etoposide
Dosage: for the standard cycles, day 1 to 3
Indication: Hodgkin's Disease
Prednisolone
Dosage: on day 1 to 14 every 21 day cycle treatment for 6 cycles
Administration route: Oral
Indication: Hodgkin's Disease
Possible Vincristine side effects in 17 year old male
Reported by a physician from Poland on 2012-08-23
Patient: 17 year old male
Reactions: Rhabdomyolysis, Disseminated Intravascular Coagulation, Pancytopenia, Pyrexia, Renal Failure, Neutropenia, Clostridial Infection, Septic Shock
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Cefepime
Meropenem
Vancocin Hydrochloride
Ifosfamide
Indication: Ewing's Sarcoma Metastatic
Netromycin
Doxorubicin Hydrochloride
Indication: Ewing's Sarcoma
Etoposide
Indication: Ewing's Sarcoma Metastatic
Metronidazole
Vincristine
Indication: Ewing's Sarcoma Metastatic
Other drugs received by patient: Fluconazole; Caspofungin Acetate
Possible Vincristine side effects in 49 year old male
Reported by a physician from Norway on 2012-08-23
Patient: 49 year old male
Reactions: Pneumocystis Jiroveci Pneumonia, Bone Marrow Failure, Pyrexia, Septic Shock, Lung Infiltration
Adverse event resulted in: death
Drug(s) suspected as cause:
Cyclophosphamide
Doxorubicin Hydrochloride
Etoposide
Cyclophosphamide
Doxorubicin Hydrochloride
Procarbazine Hydrochloride
Administration route: Oral
Bleomycin Baxter 15 000 IE Lyofilisat TIL Injeksjonsv?ske / Infusjonsv?s
Etoposide
Vincristine
Prednisolone
Administration route: Oral
Possible Vincristine side effects in female
Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-16
Patient: female, weighing 87.8 kg (193.2 pounds)
Reactions: Neuropathy Peripheral, Upper Respiratory Tract Infection, Urinary Tract Infection, Pleural Effusion, Pyrexia, Leukocytosis, Sinusitis
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Dexamethasone
Dosage: 40 mg, unk
Administration route: Oral
Indication: Mantle Cell Lymphoma
Cytarabine
Dosage: 1.87 g, cyclic
Indication: Mantle Cell Lymphoma
Velcade
Dosage: 0.7 mg/m2, cyclic
Start date: 2012-03-19
Vincristine
Dosage: 2 mg, cyclic
Indication: Mantle Cell Lymphoma
Velcade
Dosage: 2.77 mg, cyclic
Indication: Mantle Cell Lymphoma
Start date: 2011-12-31
Velcade
Dosage: 0.7 mg/m2, cyclic
Velcade
Dosage: 0.7 mg/m2, cyclic
Start date: 2012-02-26
Rituximab
Dosage: 1 mg/m2, cyclic
Indication: Mantle Cell Lymphoma
Cyclophosphamide
Indication: Mantle Cell Lymphoma
Doxorubicin Hydrochloride
Dosage: 50 mg/m2, unk
Indication: Mantle Cell Lymphoma
Methotrexate
Indication: Mantle Cell Lymphoma
Mesna
Dosage: 600 mg/m2, unk
Indication: Mantle Cell Lymphoma
Other drugs received by patient: Sennosides A+B; Nystatin; Diphenhydramine Hydrochloride; Neupogen; Fluconazole; Zofran; Valtrex; Sodium Chloride; Meperidine HCL; Potassium Chloride; Leucovorin Calcium; Zofran; Sodium Chloride; Sodium Chloride; Sodium Chloride; Heparin; Leucovorin Calcium; Allopurinol; Lovenox; Morphine; Senokot; Cipro / 00042702 /; Lovenox; Prednisolone Acetate; Stomatologicals, Mouth Preparations; Tramadol; Sodium Bicarbonate
Possible Vincristine side effects in 61 year old female
Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-13
Patient: 61 year old female
Reactions: Mucosal Inflammation, Nausea, Pyrexia, Diffuse Large B-Cell Lymphoma Recurrent, Oral Herpes
Adverse event resulted in: death
Drug(s) suspected as cause:
Cyclophosphamide
Indication: Diffuse Large B-Cell Lymphoma
Vincristine
Indication: Diffuse Large B-Cell Lymphoma
Prednisolone
Indication: Diffuse Large B-Cell Lymphoma
Etoposide
Indication: Diffuse Large B-Cell Lymphoma
Doxorubicin Hydrochloride
Indication: Diffuse Large B-Cell Lymphoma
Bleomycin Sulfate
Indication: Diffuse Large B-Cell Lymphoma
Methotrexate
Indication: Diffuse Large B-Cell Lymphoma
Possible Vincristine side effects in 46 year old female
Reported by a individual with unspecified qualification from United States on 2012-08-08
Patient: 46 year old female
Reactions: Dyspnoea, Pain in Extremity, Myelodysplastic Syndrome, General Physical Health Deterioration, Pyrexia, Pulmonary Haemorrhage, Zygomycosis, Diarrhoea, Skin Discolouration, Central Nervous System Infection, Small Intestinal Haemorrhage, Cough
Adverse event resulted in: death
Drug(s) suspected as cause:
Doxorubicin HCL
Indication: Diffuse Large B-Cell Lymphoma
Cyclophosphamide
Dosage: 400 ug, intravenous, every two months
Indication: Diffuse Large B-Cell Lymphoma
Melphalan (Melphalan) (Melphalen)
Indication: Diffuse Large B-Cell Lymphoma
Rituximab (Rituximab) (Rituximab)
Indication: Diffuse Large B-Cell Lymphoma
Vincristine
Indication: Diffuse Large B-Cell Lymphoma
Idarubicin Hydrochloride
Indication: Diffuse Large B-Cell Lymphoma
Melphalan Hydrochloride
Indication: Diffuse Large B-Cell Lymphoma
Cytarabine
Indication: Diffuse Large B-Cell Lymphoma
Carmustine
Indication: Diffuse Large B-Cell Lymphoma
Vincristine
Indication: Diffuse Large B-Cell Lymphoma
Carmustine
Indication: Diffuse Large B-Cell Lymphoma
Rituximab (Rituximab) (Rituximab)
Indication: Diffuse Large B-Cell Lymphoma
Possible Vincristine side effects in 82 year old female
Reported by a health professional (non-physician/pharmacist) from France on 2012-07-30
Patient: 82 year old female
Reactions: Confusional State, Pyrexia, Lymphoma
Drug(s) suspected as cause:
Mabthera
Indication: B-Cell Lymphoma
Cyclophosphamide
Indication: B-Cell Lymphoma
Prednisolone
Indication: B-Cell Lymphoma
Vincristine
Indication: B-Cell Lymphoma
Other drugs received by patient: Methotrexate
Possible Vincristine side effects in 17 year old male
Reported by a health professional (non-physician/pharmacist) from Poland on 2012-07-23
Patient: 17 year old male
Reactions: Abdominal Pain, Rhabdomyolysis, Pain in Extremity, Disseminated Intravascular Coagulation, Chromaturia, Pancytopenia, Pyrexia, Renal Failure, Renal Impairment, Diarrhoea, Clostridial Infection, Septic Shock
Adverse event resulted in: death, life threatening event, hospitalization
Drug(s) suspected as cause:
Etoposide
Indication: Ewing's Sarcoma Metastatic
Ifosfamide
Indication: Ewing's Sarcoma Metastatic
Cefepime
Indication: Pyrexia
Vincristine
Indication: Ewing's Sarcoma Metastatic
Doxorubicin HCL
Indication: Ewing's Sarcoma Metastatic
Netilmicin Sulfate
Indication: Pyrexia
Possible Vincristine side effects in
Reported by a physician from United Kingdom on 2012-07-17
Patient:
Reactions: Abdominal Pain, Tachycardia, Skin Toxicity, Pyrexia, Fatigue, Neuropathy Peripheral, Hepatotoxicity, Adverse Event, Dizziness, Oedema, Hallucination, Vomiting, Nausea, Gastrointestinal Toxicity, Neutropenic Sepsis, Nephropathy Toxic, Hypotension, Condition Aggravated, Adult T-Cell Lymphoma / Leukaemia, Mucosal Inflammation, Lung Disorder, Infection, Infusion Related Reaction
Adverse event resulted in: death
Drug(s) suspected as cause:
Hydrocortisone
Indication: Adult T-Cell Lymphoma / Leukaemia
Doxorubicin HCL
Dosage: on day 1 of 21 day, (cycle 1-5)
Cytarabine
Indication: Adult T-Cell Lymphoma / Leukaemia
Cyclophosphamide
Dosage: on day 1 of 21 day cycle, (cycle 1-5)
Indication: Adult T-Cell Lymphoma / Leukaemia
Zenapax
Dosage: on days 7 and 14 on cycle 1 of 21 day cycle
Indication: Adult T-Cell Lymphoma / Leukaemia
Vincristine
Dosage: (maximum 2 mg) on day 1 of 21 day cycle, (cycle 1-5)
Indication: Adult T-Cell Lymphoma / Leukaemia
Prednisolone
Dosage: on days 1-5 of 21 day cycle, (cycle 1-5)
Administration route: Oral
Indication: Adult T-Cell Lymphoma / Leukaemia
Methotrexate
Indication: Adult T-Cell Lymphoma / Leukaemia
Radiotherapy
Indication: Adult T-Cell Lymphoma / Leukaemia
Doxorubicin HCL
Dosage: on day 1 of 21 day, (cycle 1-5)
Indication: Adult T-Cell Lymphoma / Leukaemia
Other drugs received by patient: Acyclovir; Thiabendazole; Cotrim; Itraconazole
Possible Vincristine side effects in
Reported by a physician from United Kingdom on 2012-07-10
Patient:
Reactions: Abdominal Pain, Skin Toxicity, Tachycardia, Pyrexia, Fatigue, Neuropathy Peripheral, Hepatotoxicity, Adverse Event, Oedema, Dizziness, Hallucination, Vomiting, Gastrointestinal Toxicity, Nausea, Neutropenic Sepsis, Nephropathy Toxic, Hypotension, Adult T-Cell Lymphoma / Leukaemia, Condition Aggravated, Mucosal Inflammation, Lung Disorder, Infection, Infusion Related Reaction
Adverse event resulted in: death
Drug(s) suspected as cause:
Cyclophosphamide
Dosage: on day 1 of 21 day cycle, (cycle 1-5)
Indication: Adult T-Cell Lymphoma / Leukaemia
Prednisolone
Dosage: on days 1-5 of 21 day cycle, (cycle 1-5)
Administration route: Oral
Indication: Adult T-Cell Lymphoma / Leukaemia
Cytarabine
Indication: Adult T-Cell Lymphoma / Leukaemia
Doxorubicin HCL
Dosage: on day 1 of 21 day, (cycle 1-5)
Indication: Adult T-Cell Lymphoma / Leukaemia
Vincristine
Dosage: (maximum 2 mg) on day 1 of 21 day cycle, (cycle 1-5)
Indication: Adult T-Cell Lymphoma / Leukaemia
Methotrexate
Indication: Adult T-Cell Lymphoma / Leukaemia
Zenapax
Dosage: on days 7 and 14 on cycle 1 of 21 day cycle
Indication: Adult T-Cell Lymphoma / Leukaemia
Hydrocortisone
Indication: Adult T-Cell Lymphoma / Leukaemia
Radiotherapy
Indication: Adult T-Cell Lymphoma / Leukaemia
Other drugs received by patient: Cotrim; Itraconazole; Thiabendazole; Acyclovir
Possible Vincristine side effects in female
Reported by a consumer/non-health professional from Germany on 2012-07-06
Patient: female, weighing 70.0 kg (154.0 pounds)
Reactions: B-Cell Lymphoma, Anaemia, Urinary Incontinence, Abnormal Behaviour, Pulmonary Embolism, Cognitive Disorder, Pyrexia, Fall, Peripheral Sensory Neuropathy, Post Transplant Lymphoproliferative Disorder, Klebsiella Infection, Cytokine Release Syndrome, Cytomegalovirus Infection, Neutrophil Toxic Granulation Present, Traumatic Haematoma, Deep Vein Thrombosis
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Campath
Dosage: 30 mg, bid
Start date: 2009-07-23
Cyclophosphamide
Dosage: 1200 mg, once
Start date: 2009-07-23
Cyclophosphamide
Dosage: 1200 mg, once
Start date: 2009-08-20
Doxorubicin HCL
Dosage: 80 mg, once
Start date: 2009-07-07
Vincristine
Dosage: 2 mg, once
Start date: 2009-06-23
Prednisone
Dosage: 100 mg, qd for 5 days
Administration route: Oral
Start date: 2009-06-23
Filgrastim
Dosage: 3000 iu, unk
Start date: 2009-07-26
End date: 2009-08-27
Campath
Dosage: 20 mg, qd
Start date: 2009-07-07
Vincristine
Dosage: 1 mg, once
Indication: Peripheral T-Cell Lymphoma Unspecified
Start date: 2009-06-15
Vincristine
Dosage: 2 mg, once
Start date: 2009-08-20
Prednisone
Dosage: 100 mg, qd for 5 days
Administration route: Oral
Start date: 2009-09-11
Campath
Dosage: 30 mg, qd
Start date: 2009-08-06
End date: 2009-08-06
Cyclophosphamide
Dosage: 1200 mg, once
Start date: 2009-07-21
Doxorubicin HCL
Dosage: 80 mg, once
Indication: Peripheral T-Cell Lymphoma Unspecified
Start date: 2009-06-23
Prednisone
Dosage: 100 mg, qd for 5 days
Administration route: Oral
Start date: 2009-07-07
Filgrastim
Dosage: unk on days 4 through 13 of course 5
Start date: 2009-08-20
Doxorubicin HCL
Dosage: 80 mg, once
Start date: 2009-07-21
Prednisone
Dosage: 100 mg, qd for 5 days
Administration route: Oral
Indication: Peripheral T-Cell Lymphoma Unspecified
Start date: 2009-06-15
Prednisone
Dosage: 100 mg, qd for 5 days
Administration route: Oral
Start date: 2009-08-06
End date: 2009-08-10
Filgrastim
Dosage: unk on days 4 through 12 of course 6
Start date: 2009-09-08
Campath
Dosage: 30 mg, qd
Start date: 2009-09-11
End date: 2009-10-22
Cyclophosphamide
Dosage: 1250 mg, once
Indication: Peripheral T-Cell Lymphoma Unspecified
Start date: 2009-06-23
Cyclophosphamide
Dosage: 1200 mg, once
Start date: 2009-09-08
End date: 2009-09-08
Doxorubicin HCL
Dosage: 80 mg, once
Start date: 2009-08-06
End date: 2009-08-20
Doxorubicin HCL
Dosage: 80 mg, once
Start date: 2009-09-08
End date: 2009-09-08
Vincristine
Dosage: 2 mg, once
Start date: 2009-07-23
Filgrastim
Dosage: unk on days 4, 5, 6 of course 1
Indication: Peripheral T-Cell Lymphoma Unspecified
Start date: 2009-06-23
Filgrastim
Dosage: unk on days 4 through 15 of course 2
Start date: 2009-07-07
Doxorubicin HCL
Dosage: 80 mg, once
Start date: 2009-07-23
Vincristine
Dosage: 2 mg, once
Start date: 2009-07-07
Filgrastim
Dosage: unk on days 4 through 8 and day 13 of course 3
Start date: 2009-07-23
Filgrastim
Dosage: unk on days 6 + 7 and days 9 through 12 of course 4
Start date: 2009-08-06
Doxorubicin HCL
Dosage: 80 mg, once
Start date: 2009-08-20
Vincristine
Dosage: 2 mg, once
Start date: 2009-07-21
Vincristine
Prednisone
Dosage: 100 mg, qd for 5 days
Administration route: Oral
Start date: 2009-07-23
Prednisone
Dosage: 100 mg, unk
Administration route: Oral
Start date: 2009-09-08
End date: 2009-09-08
Campath
Dosage: 10 mg, qd
Indication: Peripheral T-Cell Lymphoma Unspecified
Start date: 2009-06-23
Cyclophosphamide
Dosage: 1200 mg, once
Start date: 2009-07-07
Cyclophosphamide
Dosage: 1200 mg, once
Start date: 2009-08-06
End date: 2009-08-20
Vincristine
Dosage: 2 mg, once
Start date: 2009-08-06
End date: 2009-08-20
Filgrastim
Dosage: 30000 iu, qd
Start date: 2009-09-11
End date: 2009-09-19
Other drugs received by patient: Enoxaparin Sodium; Enoxaparin Sodium; Ganciclovir; Metoprolol Tartrate; Trimethoprim + Sulfamethoxazole; Dexamethasone; Antibiotics; Torsemide; Fluticasone Propionate W; Fondaparinux Sodium; Pantoprazole; Ganciclovir; Spiriva
Possible Vincristine side effects in
Reported by a individual with unspecified qualification from Korea, Republic of on 2012-06-26
Patient:
Reactions: Abdominal Pain, Hyperbilirubinaemia, Anaemia, Alanine Aminotransferase Increased, Febrile Neutropenia, Rash, Pyrexia, Peripheral Sensory Neuropathy, Diarrhoea, Alopecia, Aspartate Aminotransferase Increased, Neutropenia, Asthenia, Thrombocytopenia
Drug(s) suspected as cause:
Vincristine
Dosage: given on day 1 of every cycle; dose: 1.4 mg/m2 ( maximum 2.0 mg)
Indication: B-Cell Lymphoma
Prednisolone
Dosage: given on days 1 to 5 of every cycle (repeated every 3 weeks)
Administration route: Oral
Indication: B-Cell Lymphoma
Mabthera
Dosage: on day 1 of every cycle
Indication: B-Cell Lymphoma
Cyclophosphamide
Dosage: given on day 1 of each cycle
Indication: B-Cell Lymphoma
Possible Vincristine side effects in
Reported by a health professional (non-physician/pharmacist) from United States on 2012-06-21
Patient:
Reactions: Urticaria, Pyrexia, Headache, Oropharyngeal Pain, Constipation, Polyneuropathy, Fatigue, Dyspepsia, Oedema Peripheral, Cough, Dyspnoea, Vomiting, Nausea, Rash, Dysgeusia, Diarrhoea, Alopecia, Neutropenia, Respiratory Tract Infection, Leukopenia, Infection, Infusion Related Reaction
Drug(s) suspected as cause:
Ofatumumab
Indication: B-Cell Lymphoma
Ofatumumab
Cyclophosphamide
Indication: B-Cell Lymphoma
Prednisone TAB
Administration route: Oral
Indication: B-Cell Lymphoma
Doxorubicin HCL
Indication: B-Cell Lymphoma
Vincristine
Indication: B-Cell Lymphoma
Other drugs received by patient: Acetaminophen; Cetirizine; Glucocorticoids
Possible Vincristine side effects in 71 year old male
Reported by a physician from United Kingdom on 2012-06-21
Patient: 71 year old male, weighing 79.7 kg (175.3 pounds)
Reactions: Haemoglobin Decreased, Chest Pain, Platelet Count Decreased, Pyrexia, Troponin Increased, Infection
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Prednisone TAB
Administration route: Oral
Indication: non-Hodgkin's Lymphoma
Start date: 2009-03-25
End date: 2009-03-29
Vincristine
Indication: non-Hodgkin's Lymphoma
Start date: 2009-03-25
End date: 2009-03-25
Rituximab
Indication: non-Hodgkin's Lymphoma
Start date: 2009-03-25
End date: 2009-03-25
Gemcitabine
Indication: non-Hodgkin's Lymphoma
Start date: 2009-03-25
End date: 2009-04-01
Neulasta
Indication: non-Hodgkin's Lymphoma
Start date: 2009-03-25
End date: 2009-04-02
Cyclophosphamide
Indication: non-Hodgkin's Lymphoma
Start date: 2009-03-25
End date: 2009-03-25
Other drugs received by patient: Tramadol HCL; Metoclopramide; Cotrim
Possible Vincristine side effects in 49 year old male
Reported by a physician from Norway on 2012-06-14
Patient: 49 year old male
Reactions: Off Label Use, Pneumocystis Jiroveci Pneumonia, Bone Marrow Failure, Pyrexia, Lung Infiltration, Septic Shock, Infection
Adverse event resulted in: death
Drug(s) suspected as cause:
Etoposide
Bleomycin Sulfate
Doxorubicin HCL
Vincristine
Prednisolone
Administration route: Oral
Procarbazine Hydrochloride
Administration route: Oral
Cyclophosphamide
Possible Vincristine side effects in male
Reported by a physician from United States on 2012-06-12
Patient: male, weighing 14.6 kg (32.1 pounds)
Reactions: Large Intestine Perforation, Vomiting, Dehydration, Pancytopenia, Pyrexia, Asthenia, Abdominal Tenderness
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Vincristine
Dosage: total dose administered 2.76 mg
Dexamethasone
Dosage: total dose administered 80 mg
PEG-L-Asparaginase (Pegaspargase, Oncospar)
Dosage: total dose administered 1550 unit
Cytarabine
Dosage: total dose administered 70 mg
Methotrexate
Dosage: total dose administered 12 mg
Possible Vincristine side effects in 49 year old male
Reported by a health professional (non-physician/pharmacist) from Norway on 2012-06-11
Patient: 49 year old male
Reactions: Pneumocystis Jiroveci Pneumonia, Bone Marrow Failure, Pyrexia, Lung Infiltration, Septic Shock, Infection
Adverse event resulted in: death
Drug(s) suspected as cause:
Doxorubicin HCL
Dosage: 35mg/m2,on d1 for escalated cycles
Indication: Hodgkin's Disease
Bleomycin Sulfate
Dosage: on d8
Indication: Hodgkin's Disease
Etoposide
Dosage: 100mg/m2 for the standard cycles d1 to 3; 200mg/m2 for the escalated cycles from d1-3 iv
Indication: Hodgkin's Disease
Cyclophosphamide
Dosage: 650mg/m2 standard cycles 1250 for the escalated cycles
Indication: Hodgkin's Disease
Vincristine
Dosage: on d8
Indication: Hodgkin's Disease
Prednisolone
Dosage: on days 1 to 14 in every 21 day cycle treatment for 6 cycles
Administration route: Oral
Indication: Hodgkin's Disease
Procarbazine Hydrochloride
Dosage: day1-7
Administration route: Oral
Indication: Hodgkin's Disease
Possible Vincristine side effects in 17 year old female
Reported by a physician from United States on 2012-06-08
Patient: 17 year old female, weighing 47.6 kg (104.7 pounds)
Reactions: Blood Bilirubin Increased, Pyrexia, Caecitis, Loss of Consciousness, Oedema Peripheral, Pulmonary Oedema, Hypocalcaemia, Acute Respiratory Distress Syndrome, Melaena, Hypertriglyceridaemia, Epistaxis, Dysphagia, Anaemia, Hyperglycaemia, General Physical Health Deterioration, Eating Disorder, Tremor, Cerebral Infarction, Depressed Level of Consciousness, Neutropenia, Confusional State, Dyskinesia, Somnolence, Splenic Infarction, Hypokalaemia, Pleural Effusion, White Blood Cell Count Decreased, Cerebrovascular Accident, Ascites, Diarrhoea, Hypophagia, Hypoalbuminaemia, Sinus Tachycardia, Hypertension
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Mercaptopurine
Dosage: 60mgm2 cyclic
Administration route: Oral
Indication: T-Cell Type Acute Leukaemia
Vincristine
Dosage: 1.5mgm2 cyclic
Indication: T-Cell Type Acute Leukaemia
Cyclophosphamide
Dosage: 1000mgm2 cyclic
Indication: T-Cell Type Acute Leukaemia
Methotrexate
Indication: T-Cell Type Acute Leukaemia
Oncaspar
Indication: T-Cell Type Acute Leukaemia
Nelarabine
Dosage: 650mgm2 cyclic
Indication: T-Cell Type Acute Leukaemia
Start date: 2012-04-13
Cytarabine
Dosage: 75mgm2 cyclic
Indication: T-Cell Type Acute Leukaemia
Dalteparin Sodium
Indication: Product Used FOR Unknown Indication
Other drugs received by patient: Nystatin; Lansoprazole; Insulin Aspart; Piperacillin and Tazobactam; Vancomycin; Voriconazole
Possible Vincristine side effects in 63 year old male
Reported by a physician from Germany on 2012-06-07
Patient: 63 year old male
Reactions: Dehydration, Febrile Neutropenia, Pyrexia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Vincristine
Indication: non-Hodgkin's Lymphoma
Cyclophosphamide
Indication: non-Hodgkin's Lymphoma
Mabthera
Indication: non-Hodgkin's Lymphoma
Doxorubicin HCL
Indication: non-Hodgkin's Lymphoma
Prednisone TAB
Indication: non-Hodgkin's Lymphoma
Possible Vincristine side effects in female
Reported by a physician from United States on 2012-06-05
Patient: female
Reactions: Neutropenia, Device Related Infection, Pyrexia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Methotrexate
Dosage: itrc
Indication: Acute Lymphocytic Leukaemia
Start date: 2012-04-23
End date: 2012-04-23
Dasatinib
Dosage: 45 milligram;
Administration route: Oral
Indication: Acute Lymphocytic Leukaemia
Start date: 2012-04-30
Cytarabine
Indication: Acute Lymphocytic Leukaemia
Start date: 2012-04-16
End date: 2012-04-16
Daunorubicin Hydrochloride
Indication: Acute Lymphocytic Leukaemia
Start date: 2012-04-16
End date: 2012-04-30
Dexamethasone
Dosage: 2/1 day
Indication: Acute Lymphocytic Leukaemia
Start date: 2012-04-16
End date: 2012-04-29
Pegaspargase
Indication: Acute Lymphocytic Leukaemia
Start date: 2012-04-19
End date: 2012-04-19
Vincristine
Dosage: 7 day
Indication: Acute Lymphocytic Leukaemia
Start date: 2012-04-16
End date: 2012-04-30
Other drugs received by patient: Furosemide; Nystatin; Zantac; Ondansetron
Possible Vincristine side effects in 49 year old male
Reported by a physician from Norway on 2012-06-05
Patient: 49 year old male
Reactions: Pneumocystis Jiroveci Pneumonia, Bone Marrow Failure, Pyrexia, Lung Infiltration, Septic Shock, Infection
Adverse event resulted in: death
Drug(s) suspected as cause:
Cyclophosphamide
Dosage: for standard cycles on day 1
Indication: Hodgkin's Disease
Vincristine
Dosage: on day 8
Indication: Hodgkin's Disease
Prednisolone
Dosage: on day 1 to 14
Administration route: Oral
Indication: Hodgkin's Disease
Procarbazine Hydrochloride
Dosage: day 1 to 7
Administration route: Oral
Indication: Hodgkin's Disease
Doxorubicin HCL
Dosage: for escalated cycles on day 1
Etoposide
Dosage: for the standard cycles, day 1 to 3
Bleomycin Sulfate
Dosage: on day 8
Indication: Hodgkin's Disease
Etoposide
Dosage: for the escalated cycles on day 1 to 3
Indication: Hodgkin's Disease
Cyclophosphamide
Dosage: for escalated cycles on day 1
Doxorubicin HCL
Dosage: for standard cycles
Indication: Hodgkin's Disease
Possible Vincristine side effects in
Reported by a physician from Germany on 2012-06-01
Patient:
Reactions: Respiratory Disorder, Pain, Myelodysplastic Syndrome, Pyrexia, Neoplasm, Death, Completed Suicide, Thrombocytopenia, Vomiting, Nausea, Anaemia, Acute Myeloid Leukaemia, Toxicity To Various Agents, Haematotoxicity, Hodgkin's Disease, Mucosal Inflammation, Accident, Alopecia, Gastrointestinal Disorder, Nervous System Disorder, non-Hodgkin's Lymphoma, Cardiovascular Disorder, Leukopenia, Infection
Adverse event resulted in: death
Drug(s) suspected as cause:
Cyclophosphamide
Indication: Hodgkin's Disease
Etoposide
Indication: Hodgkin's Disease
Vincristine
Indication: Hodgkin's Disease
Procarbazine Hydrochloride
Indication: Hodgkin's Disease
Prednisone TAB
Indication: Hodgkin's Disease
Doxorubicin HCL
Indication: Hodgkin's Disease
Bleomycin Sulfate
Indication: Hodgkin's Disease
Other drugs received by patient: Radiotherapy
Possible Vincristine side effects in female
Reported by a physician from France on 2012-05-29
Patient: female, weighing 40.0 kg (88.0 pounds)
Reactions: Febrile Neutropenia, General Physical Health Deterioration, Pyrexia, Neutrophil Count Decreased
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Vincristine
Indication: non-Hodgkin's Lymphoma
Start date: 2011-10-27
End date: 2012-04-13
Prednisone TAB
Indication: non-Hodgkin's Lymphoma
Start date: 2011-10-27
End date: 2012-04-13
Adriamycin PFS
Indication: non-Hodgkin's Lymphoma
Start date: 2011-10-27
End date: 2012-04-13
Istodax
Dosage: 14 milligram
Indication: non-Hodgkin's Lymphoma
Start date: 2011-10-27
End date: 2012-04-12
Cyclophosphamide
Indication: non-Hodgkin's Lymphoma
Start date: 2011-10-27
End date: 2012-04-13
Possible Vincristine side effects in female
Reported by a individual with unspecified qualification from United States on 2012-05-25
Patient: female, weighing 14.9 kg (32.8 pounds)
Reactions: Anaemia, Hyponatraemia, Rash, Pyrexia, Ascites, Abdominal Pain Upper, Abdominal Compartment Syndrome, Respiratory Failure, Pneumonia Herpes Viral, Bone Marrow Failure, Neutropenia, Thrombocytopenia, Cardiac Arrest, Septic Shock, Infection in AN Immunocompromised Host
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Vincristine
Dosage: .99 mg
Methotrexate
Dosage: 24.5 mg
Dexamethasone
Dosage: 17.5 ml
Mercaptopurine
Dosage: 460 mg
Possible Vincristine side effects in female
Reported by a physician from United States on 2012-05-25
Patient: female
Reactions: Pyrexia, Device Related Infection, Neutrophil Count Decreased
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Cytarabine
Indication: Acute Lymphocytic Leukaemia
Start date: 2012-04-16
End date: 2012-04-16
Dasatinib
Dosage: 45 milligram;
Administration route: Oral
Indication: Acute Lymphocytic Leukaemia
Start date: 2012-04-30
Pegaspargase
Indication: Acute Lymphocytic Leukaemia
Start date: 2012-04-19
End date: 2012-04-19
Vincristine
Dosage: 7 day
Indication: Acute Lymphocytic Leukaemia
Start date: 2012-04-16
End date: 2012-04-30
Dexamethasone
Dosage: 2/1 day
Indication: Acute Lymphocytic Leukaemia
Start date: 2012-04-16
End date: 2012-04-29
Daunorubicin Hydrochloride
Indication: Acute Lymphocytic Leukaemia
Start date: 2012-04-16
End date: 2012-04-30
Methotrexate
Dosage: itrc
Indication: Acute Lymphocytic Leukaemia
Start date: 2012-04-23
End date: 2012-04-23
Other drugs received by patient: Zantac; Nystatin; Ondansetron; Furosemide
Possible Vincristine side effects in 10 year old male
Reported by a physician from United States on 2012-05-24
Patient: 10 year old male, weighing 22.3 kg (49.1 pounds)
Reactions: Pyrexia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Doxorubicin HCL
Dosage: 27 mg, qd on day 1 and 5
Indication: Acute Lymphocytic Leukaemia
Start date: 2012-03-31
End date: 2012-05-01
Methylprednisolone Acetate
Dosage: 9.7 mg, q8h on day 4 to day 32
Indication: Acute Lymphocytic Leukaemia
Methotrexate
Dosage: unk
Indication: Acute Lymphocytic Leukaemia
Start date: 2012-05-03
Etoposide
Dosage: unk
Indication: Acute Lymphocytic Leukaemia
Start date: 2012-05-10
Afinitor
Dosage: 2 mg, qd on day 1 to day 32
Administration route: Oral
Indication: Acute Lymphocytic Leukaemia
Start date: 2012-03-31
End date: 2012-05-01
Oncaspar
Dosage: 2275 iu, qd on days 4 to 32
Indication: Acute Lymphocytic Leukaemia
Start date: 2012-03-31
End date: 2012-05-01
Vincristine
Dosage: 1.4 mg, qd on day 4, 11, 18 and 25
Indication: Acute Lymphocytic Leukaemia
Start date: 2012-03-31
End date: 2012-05-01
Cytoxan
Dosage: unk
Indication: Acute Lymphocytic Leukaemia
Start date: 2012-05-10
Other drugs received by patient: Leucovorin Calcium; Ondansetron; Senna-Mint WAF; Colace; Sulfamethoxypyrazine / Trimethoprim; Ondansetron; Concerta; Calcium Carbonate; Clonidine
Possible Vincristine side effects in
Reported by a health professional (non-physician/pharmacist) from United States on 2012-05-18
Patient:
Reactions: Urticaria, Headache, Pyrexia, Oropharyngeal Pain, Constipation, Polyneuropathy, Fatigue, Dyspepsia, Oedema Peripheral, Cough, Dyspnoea, Vomiting, Nausea, Rash, Dysgeusia, Diarrhoea, Alopecia, Neutropenia, Respiratory Tract Infection, Leukopenia, Infection, Infusion Related Reaction
Drug(s) suspected as cause:
Vincristine
Indication: B-Cell Lymphoma
Cyclophosphamide
Indication: B-Cell Lymphoma
Prednisone
Administration route: Oral
Indication: B-Cell Lymphoma
Ofatumumab
Indication: B-Cell Lymphoma
Doxorubicin HCL
Indication: B-Cell Lymphoma
Ofatumumab
Other drugs received by patient: Cetirizine; Acetaminophen; Glucocorticoids
Possible Vincristine side effects in 1 year old female
Reported by a physician from United States on 2012-05-10
Patient: 1 year old female, weighing 7.6 kg (16.8 pounds)
Reactions: Dyspnoea, Vomiting, Hypothermia, Nausea, Chills, Pyrexia, Peripheral Sensory Neuropathy, Sinus Bradycardia, Hypokalaemia, Diarrhoea, Ileus, Hypoalbuminaemia, Lung Infiltration, Candidiasis, Influenza Like Illness
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Vincristine
Dosage: 1.5 mg/m2, cyclic
Indication: B Precursor Type Acute Leukaemia
Start date: 2012-03-23
End date: 2012-03-23
Doxorubicin HCL
Dosage: 60 mg/m2, cyclic
Indication: B Precursor Type Acute Leukaemia
Start date: 2012-03-23
End date: 2012-03-23
Prednisone TAB
Dosage: 20 mg/m2, unk
Administration route: Oral
Indication: B Precursor Type Acute Leukaemia
Start date: 2012-03-23
End date: 2012-03-24
Cytarabine
Dosage: unk mg, cyclic
Indication: B Precursor Type Acute Leukaemia
End date: 2012-03-22
Velcade
Dosage: 1.3 mg/m2, cyclic
Indication: B Precursor Type Acute Leukaemia
Start date: 2012-03-23
End date: 2012-03-23
Possible Vincristine side effects in male
Reported by a physician from Denmark on 2012-05-08
Patient: male, weighing 81.0 kg (178.2 pounds)
Reactions: Pneumonia, Pulmonary Embolism, Febrile Neutropenia, Pyrexia, Muscle Rupture
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Vincristine
Start date: 2011-04-26
Doxorubicin HCL
Start date: 2011-04-26
Cyclophosphamide
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-08-03
Cyclophosphamide
Start date: 2011-04-26
Prednisone TAB
Administration route: Oral
Start date: 2011-04-26
Neupogen
Start date: 2011-06-29
Doxorubicin HCL
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-08-03
Doxorubicin HCL
Start date: 2011-06-28
Vincristine
Dosage: dosage form: unspecified
Indication: Diffuse Large B-Cell Lymphoma
Vincristine
Start date: 2011-06-28
Rituximab
Start date: 2011-06-28
Rituximab
Start date: 2011-05-03
Rituximab
Start date: 2011-04-26
Rituximab
Start date: 2011-07-02
End date: 2011-07-02
Neupogen
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-08-04
Cyclophosphamide
Dosage: dosage form: unspecified
Start date: 2011-06-28
Neupogen
Start date: 2011-04-27
Prednisone TAB
Administration route: Oral
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-08-03
Prednisone TAB
Administration route: Oral
Start date: 2011-06-28
Rituximab
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-08-03
Other drugs received by patient: Morphine Sulfate; Morphine; Acyclovir; Sennoside A+B; Lansoprazole; Furosemide; Enoxaparin Sodium; Amlodipine Besylate; Lactulose; Allopurinol; Sulfamethoxazole + Trimethoprim; Movicol / 01625101 /
Page 1 Next >>
|
